Blog: A new era for refractive surgery in the United States: STAAR EVO ICL wins FDA approval
May 22nd 2022There’s a new alternative to LASIK in the United States. In March of 2022, the FDA approved STAAR Surgical’s EVO/EVO+ VISIAN Implantable Collamer Lens (ICL) and Toric Implantable Collamer Lens (TICL).
Read More
Study finds progressive declines in vision in aging patients with diffractive multifocal IOLs
January 14th 2022According to investigators, patients implanted with diffractive multifocal IOLs had notable declines in the corrected distance visual acuity, distance corrected near VA, and near area of focus with aging
Read More
AcuFocus receives Approvable Letter from FDA for small aperture IOL
December 7th 2021The company will begin commercialization of the IC-8 small aperture IOL, used for cataract patients, upon successful completion of the manufacturing facility inspections and receipt of an official approval order from the FDA, which the company estimates in Q2 2022.
Read More